Listed

Voyager Therapeutics, Inc.

VYGRNasdaqCIK 1640266HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$3.2m, Q2 FY2026
Operating income−$26.4m, Q2 FY2026
Net income−$24.5m, Q2 FY2026
Voyager Therapeutics, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m4.6Revenue, Q3 FY2023, three months to 2023-09-30$4.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-12, accession 0001558370-24-015304.Report this figure90.1Revenue, Q4 FY2023, three months to 2023-12-31$90.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-09, accession 0001104659-26-025197. Derived: 12-month figure less the 9-month figure.Report this figure19.5Revenue, Q1 FY2024, three months to 2024-03-31$19.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-06, accession 0001558370-25-006484.Report this figure29.6Revenue, Q2 FY2024, three months to 2024-06-30$29.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-06, accession 0001558370-25-010511.Report this figure24.6Revenue, Q3 FY2024, three months to 2024-09-30$24.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figure6.3Revenue, Q4 FY2024, three months to 2024-12-31$6.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-09, accession 0001104659-26-025197. Derived: 12-month figure less the 9-month figure.Report this figure6.5Revenue, Q1 FY2025, three months to 2025-03-31$6.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001104659-26-057097.Report this figure5.2Revenue, Q2 FY2025, three months to 2025-06-30$5.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure13.4Revenue, Q3 FY2025, three months to 2025-09-30$13.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figure15.3Revenue, Q4 FY2025, three months to 2025-12-31$15.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-09, accession 0001104659-26-025197. Derived: 12-month figure less the 9-month figure.Report this figure2.6Revenue, Q1 FY2026, three months to 2026-03-31$2.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001104659-26-057097.Report this figure3.2Revenue, Q2 FY2026, three months to 2026-06-30$3.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure
Research and development$m25.9Research and development, Q3 FY2023, three months to 2023-09-30$25.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001558370-24-015304.Report this figure25.8Research and development, Q4 FY2023, three months to 2023-12-31$25.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-09, accession 0001104659-26-025197. Derived: 12-month figure less the 9-month figure.Report this figure27.1Research and development, Q1 FY2024, three months to 2024-03-31$27.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-06, accession 0001558370-25-006484.Report this figure34.5Research and development, Q2 FY2024, three months to 2024-06-30$34.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-06, accession 0001558370-25-010511.Report this figure30.2Research and development, Q3 FY2024, three months to 2024-09-30$30.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figure35.6Research and development, Q4 FY2024, three months to 2024-12-31$35.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-09, accession 0001104659-26-025197. Derived: 12-month figure less the 9-month figure.Report this figure31.5Research and development, Q1 FY2025, three months to 2025-03-31$31.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001104659-26-057097.Report this figure31.3Research and development, Q2 FY2025, three months to 2025-06-30$31.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure35.9Research and development, Q3 FY2025, three months to 2025-09-30$35.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figure36.0Research and development, Q4 FY2025, three months to 2025-12-31$36.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-09, accession 0001104659-26-025197. Derived: 12-month figure less the 9-month figure.Report this figure24.6Research and development, Q1 FY2026, three months to 2026-03-31$24.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001104659-26-057097.Report this figure22.0Research and development, Q2 FY2026, three months to 2026-06-30$22.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure
Operating income$m(29.5)Operating income, Q3 FY2023, three months to 2023-09-30−$29.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001558370-24-015304.Report this figure54.1Operating income, Q4 FY2023, three months to 2023-12-31$54.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-09, accession 0001104659-26-025197. Derived: 12-month figure less the 9-month figure.Report this figure(16.2)Operating income, Q1 FY2024, three months to 2024-03-31−$16.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-06, accession 0001558370-25-006484.Report this figure(15.0)Operating income, Q2 FY2024, three months to 2024-06-30−$15.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0001558370-25-010511.Report this figure(13.8)Operating income, Q3 FY2024, three months to 2024-09-30−$13.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figure(38.3)Operating income, Q4 FY2024, three months to 2024-12-31−$38.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-09, accession 0001104659-26-025197. Derived: 12-month figure less the 9-month figure.Report this figure(34.7)Operating income, Q1 FY2025, three months to 2025-03-31−$34.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001104659-26-057097.Report this figure(36.6)Operating income, Q2 FY2025, three months to 2025-06-30−$36.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure(30.6)Operating income, Q3 FY2025, three months to 2025-09-30−$30.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figure(29.9)Operating income, Q4 FY2025, three months to 2025-12-31−$29.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-09, accession 0001104659-26-025197. Derived: 12-month figure less the 9-month figure.Report this figure(30.3)Operating income, Q1 FY2026, three months to 2026-03-31−$30.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001104659-26-057097.Report this figure(26.4)Operating income, Q2 FY2026, three months to 2026-06-30−$26.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure
Income tax$m(0.2)Income tax, Q3 FY2023, three months to 2023-09-30−$177.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0001558370-24-015304.Report this figure0.8Income tax, Q4 FY2023, three months to 2023-12-31$822.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-09, accession 0001104659-26-025197. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$14.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-06, accession 0001558370-25-006484.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$24.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-06, accession 0001558370-25-010511.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$43.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figure0.6Income tax, Q4 FY2024, three months to 2024-12-31$584.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-09, accession 0001104659-26-025197. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$37.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001104659-26-057097.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$15.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure0.1Income tax, Q3 FY2025, three months to 2025-09-30$83.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$9.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-09, accession 0001104659-26-025197. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$14.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001104659-26-057097.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$20.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure
Net income$m(25.9)Net income, Q3 FY2023, three months to 2023-09-30−$25.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001558370-24-015304.Report this figure56.4Net income, Q4 FY2023, three months to 2023-12-31$56.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-09, accession 0001104659-26-025197. Derived: 12-month figure less the 9-month figure.Report this figure(11.3)Net income, Q1 FY2024, three months to 2024-03-31−$11.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figure(10.1)Net income, Q2 FY2024, three months to 2024-06-30−$10.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figure(9.0)Net income, Q3 FY2024, three months to 2024-09-30−$9.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figure(34.5)Net income, Q4 FY2024, three months to 2024-12-31−$34.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-09, accession 0001104659-26-025197. Derived: 12-month figure less the 9-month figure.Report this figure(31.0)Net income, Q1 FY2025, three months to 2025-03-31−$31.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure(33.4)Net income, Q2 FY2025, three months to 2025-06-30−$33.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure(27.9)Net income, Q3 FY2025, three months to 2025-09-30−$27.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figure(27.4)Net income, Q4 FY2025, three months to 2025-12-31−$27.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-09, accession 0001104659-26-025197. Derived: 12-month figure less the 9-month figure.Report this figure(27.9)Net income, Q1 FY2026, three months to 2026-03-31−$27.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure(24.5)Net income, Q2 FY2026, three months to 2026-06-30−$24.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure
Diluted EPS$ per share(0.59)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001558370-24-015304.Report this figurenot reported(0.20)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-06, accession 0001558370-25-006484.Report this figure(0.18)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0001558370-25-010511.Report this figure(0.16)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figurenot reported(0.53)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.53 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001104659-26-057097.Report this figure(0.57)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.57 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure(0.47)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figurenot reported(0.47)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001104659-26-057097.Report this figure(0.40)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure
Basic EPS$ per share(0.59)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.59 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001558370-24-015304.Report this figurenot reported(0.20)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-06, accession 0001558370-25-006484.Report this figure(0.18)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-06, accession 0001558370-25-010511.Report this figure(0.16)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figurenot reported(0.53)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.53 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001104659-26-057097.Report this figure(0.57)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.57 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure(0.47)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.47 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figurenot reported(0.47)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.47 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001104659-26-057097.Report this figure(0.40)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure

Balance sheet

Cash and equivalents$35.8m, Q2 FY2026
Shareholders' equity$154.4m, Q2 FY2026
Voyager Therapeutics, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m65.3Cash and equivalents, Q3 FY2023, at 2023-09-30$65.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-06, accession 0001558370-23-017754.Report this figure68.8Cash and equivalents, FY2023, at 2023-12-31$68.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-11, accession 0001558370-25-002703.Report this figure143Cash and equivalents, Q1 FY2024, at 2024-03-31$143.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-13, accession 0001558370-24-007953.Report this figure76.1Cash and equivalents, Q2 FY2024, at 2024-06-30$76.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-06, accession 0001558370-24-011073.Report this figure113Cash and equivalents, Q3 FY2024, at 2024-09-30$112.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001558370-24-015304.Report this figure71.4Cash and equivalents, FY2024, at 2024-12-31$71.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-09, accession 0001104659-26-025197.Report this figure74.8Cash and equivalents, Q1 FY2025, at 2025-03-31$74.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-06, accession 0001558370-25-006484.Report this figure43.9Cash and equivalents, Q2 FY2025, at 2025-06-30$43.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-06, accession 0001558370-25-010511.Report this figure45.1Cash and equivalents, Q3 FY2025, at 2025-09-30$45.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figure65.3Cash and equivalents, FY2025, at 2025-12-31$65.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure43.3Cash and equivalents, Q1 FY2026, at 2026-03-31$43.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001104659-26-057097.Report this figure35.8Cash and equivalents, Q2 FY2026, at 2026-06-30$35.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure
Current assets$m262Current assets, Q3 FY2023, at 2023-09-30$261.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-06, accession 0001558370-23-017754.Report this figure320Current assets, FY2023, at 2023-12-31$319.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-11, accession 0001558370-25-002703.Report this figure409Current assets, Q1 FY2024, at 2024-03-31$409.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-13, accession 0001558370-24-007953.Report this figure382Current assets, Q2 FY2024, at 2024-06-30$381.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0001558370-24-011073.Report this figure373Current assets, Q3 FY2024, at 2024-09-30$373.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001558370-24-015304.Report this figure277Current assets, FY2024, at 2024-12-31$276.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-09, accession 0001104659-26-025197.Report this figure245Current assets, Q1 FY2025, at 2025-03-31$245.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-06, accession 0001558370-25-006484.Report this figure228Current assets, Q2 FY2025, at 2025-06-30$227.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0001558370-25-010511.Report this figure220Current assets, Q3 FY2025, at 2025-09-30$219.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figure203Current assets, FY2025, at 2025-12-31$202.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure147Current assets, Q1 FY2026, at 2026-03-31$147.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001104659-26-057097.Report this figure125Current assets, Q2 FY2026, at 2026-06-30$125.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure
Total assets$m295Total assets, Q3 FY2023, at 2023-09-30$294.7m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-06, accession 0001558370-23-017754.Report this figure351Total assets, FY2023, at 2023-12-31$351.3m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-11, accession 0001558370-25-002703.Report this figure470Total assets, Q1 FY2024, at 2024-03-31$469.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-13, accession 0001558370-24-007953.Report this figure436Total assets, Q2 FY2024, at 2024-06-30$436.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0001558370-24-011073.Report this figure426Total assets, Q3 FY2024, at 2024-09-30$426.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001558370-24-015304.Report this figure393Total assets, FY2024, at 2024-12-31$393.1m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-09, accession 0001104659-26-025197.Report this figure353Total assets, Q1 FY2025, at 2025-03-31$353.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-06, accession 0001558370-25-006484.Report this figure322Total assets, Q2 FY2025, at 2025-06-30$322.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0001558370-25-010511.Report this figure288Total assets, Q3 FY2025, at 2025-09-30$288.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figure252Total assets, FY2025, at 2025-12-31$252.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure219Total assets, Q1 FY2026, at 2026-03-31$219.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001104659-26-057097.Report this figure198Total assets, Q2 FY2026, at 2026-06-30$197.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure
Current liabilities$m61.7Current liabilities, Q3 FY2023, at 2023-09-30$61.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-06, accession 0001558370-23-017754.Report this figure64.5Current liabilities, FY2023, at 2023-12-31$64.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-11, accession 0001558370-25-002703.Report this figure72.6Current liabilities, Q1 FY2024, at 2024-03-31$72.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-13, accession 0001558370-24-007953.Report this figure40.1Current liabilities, Q2 FY2024, at 2024-06-30$40.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0001558370-24-011073.Report this figure44.2Current liabilities, Q3 FY2024, at 2024-09-30$44.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001558370-24-015304.Report this figure49.8Current liabilities, FY2024, at 2024-12-31$49.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-09, accession 0001104659-26-025197.Report this figure40.2Current liabilities, Q1 FY2025, at 2025-03-31$40.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-06, accession 0001558370-25-006484.Report this figure42.0Current liabilities, Q2 FY2025, at 2025-06-30$42.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0001558370-25-010511.Report this figure35.5Current liabilities, Q3 FY2025, at 2025-09-30$35.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figure26.5Current liabilities, FY2025, at 2025-12-31$26.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure17.5Current liabilities, Q1 FY2026, at 2026-03-31$17.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001104659-26-057097.Report this figure16.7Current liabilities, Q2 FY2026, at 2026-06-30$16.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure
Total liabilities$m118Total liabilities, Q3 FY2023, at 2023-09-30$118.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-06, accession 0001558370-23-017754.Report this figure115Total liabilities, FY2023, at 2023-12-31$115.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-11, accession 0001558370-25-002703.Report this figure129Total liabilities, Q1 FY2024, at 2024-03-31$128.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-13, accession 0001558370-24-007953.Report this figure101Total liabilities, Q2 FY2024, at 2024-06-30$100.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0001558370-24-011073.Report this figure95.7Total liabilities, Q3 FY2024, at 2024-09-30$95.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001558370-24-015304.Report this figure93.3Total liabilities, FY2024, at 2024-12-31$93.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-09, accession 0001104659-26-025197.Report this figure80.5Total liabilities, Q1 FY2025, at 2025-03-31$80.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-06, accession 0001558370-25-006484.Report this figure78.2Total liabilities, Q2 FY2025, at 2025-06-30$78.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-06, accession 0001558370-25-010511.Report this figure68.5Total liabilities, Q3 FY2025, at 2025-09-30$68.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figure56.2Total liabilities, FY2025, at 2025-12-31$56.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure45.7Total liabilities, Q1 FY2026, at 2026-03-31$45.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001104659-26-057097.Report this figure43.4Total liabilities, Q2 FY2026, at 2026-06-30$43.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure
Shareholders' equity$m176Shareholders' equity, Q3 FY2023, at 2023-09-30$176.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001558370-24-015304.Report this figure236Shareholders' equity, FY2023, at 2023-12-31$236.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-09, accession 0001104659-26-025197.Report this figure341Shareholders' equity, Q1 FY2024, at 2024-03-31$340.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figure335Shareholders' equity, Q2 FY2024, at 2024-06-30$335.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figure330Shareholders' equity, Q3 FY2024, at 2024-09-30$330.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figure300Shareholders' equity, FY2024, at 2024-12-31$299.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure273Shareholders' equity, Q1 FY2025, at 2025-03-31$272.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure244Shareholders' equity, Q2 FY2025, at 2025-06-30$243.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure220Shareholders' equity, Q3 FY2025, at 2025-09-30$219.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figure196Shareholders' equity, FY2025, at 2025-12-31$196.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure174Shareholders' equity, Q1 FY2026, at 2026-03-31$173.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure154Shareholders' equity, Q2 FY2026, at 2026-06-30$154.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure

Cash flow

Operating cash flow−$25.8m, Q2 FY2026
Capital expenditure$0, Q2 FY2026
Voyager Therapeutics, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(21.1)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$21.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001558370-24-015304. Derived: 9-month figure less the 6-month figure.Report this figure(23.8)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$23.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-09, accession 0001104659-26-025197. Derived: 12-month figure less the 9-month figure.Report this figure58.8Operating cash flow, Q1 FY2024, three months to 2024-03-31$58.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-06, accession 0001558370-25-006484.Report this figure(31.6)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$31.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0001558370-25-010511. Derived: 6-month figure less the 3-month figure.Report this figure(28.0)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$28.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001104659-25-108846. Derived: 9-month figure less the 6-month figure.Report this figure(14.5)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$14.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-09, accession 0001104659-26-025197. Derived: 12-month figure less the 9-month figure.Report this figure(37.9)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$37.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001104659-26-057097.Report this figure(33.3)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$33.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001640266-26-000006. Derived: 6-month figure less the 3-month figure.Report this figure(31.0)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$31.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001104659-25-108846. Derived: 9-month figure less the 6-month figure.Report this figure(30.3)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$30.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-09, accession 0001104659-26-025197. Derived: 12-month figure less the 9-month figure.Report this figure(33.4)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$33.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001104659-26-057097.Report this figure(25.8)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$25.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001640266-26-000006. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.8Capital expenditure, Q3 FY2023, three months to 2023-09-30$782.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0001558370-24-015304. Derived: 9-month figure less the 6-month figure.Report this figure0.8Capital expenditure, Q4 FY2023, three months to 2023-12-31$755.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-09, accession 0001104659-26-025197. Derived: 12-month figure less the 9-month figure.Report this figure2.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$2.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-06, accession 0001558370-25-006484.Report this figure1.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$967.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-06, accession 0001558370-25-010511. Derived: 6-month figure less the 3-month figure.Report this figure0.3Capital expenditure, Q3 FY2024, three months to 2024-09-30$258.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001104659-25-108846. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2024, three months to 2024-12-31$155.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-09, accession 0001104659-26-025197. Derived: 12-month figure less the 9-month figure.Report this figure0.7Capital expenditure, Q1 FY2025, three months to 2025-03-31$658.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001104659-26-057097.Report this figure1.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001640266-26-000006. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2025, three months to 2025-09-30$207.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001104659-25-108846. Derived: 9-month figure less the 6-month figure.Report this figure0.6Capital expenditure, Q4 FY2025, three months to 2025-12-31$626.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-09, accession 0001104659-26-025197. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$14.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001104659-26-057097.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001640266-26-000006. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)60.55m, Q2 FY2026
Voyager Therapeutics, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares39.6Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3039,570,394 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-06, accession 0001558370-23-017754.Report this figure42.2Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3142,161,326 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-13, accession 0001558370-24-007953.Report this figure43.5Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3043,520,137 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0001558370-24-011073.Report this figure43.9Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3043,864,838 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001558370-24-015304.Report this figure57.1Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3157,117,046 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-06, accession 0001558370-25-006484.Report this figure57.7Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3057,721,934 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0001558370-25-010511.Report this figure57.9Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3057,851,110 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figure58.3Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3158,349,769 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001104659-26-057097.Report this figure58.7Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3058,666,460 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure58.8Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3058,803,015 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001104659-25-108846.Report this figure59.5Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3159,496,329 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001104659-26-057097.Report this figure60.5Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3060,547,863 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure

Shares outstanding: 61.62mShares outstanding, period not labelled, at 2026-07-3061,617,948 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001640266-26-000006.Report this figure at Jul 30, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. Listed shows no prices and gives no investment advice.